Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone

被引：71

作者：

Kung, Pei-Pei ^{[1
]}

Huang, Buwen ^{[1
]}

Zhang, Gang ^{[1
]}

Zhou, Joe Zhongxiang ^{[1
]}

Wang, Jeff ^{[1
]}

Digits, Jennifer A. ^{[1
]}

Skaptason, Judith ^{[1
]}

Yamazaki, Shinji ^{[1
]}

Neul, David ^{[1
]}

Zientek, Michael ^{[1
]}

Elleraas, Jeff ^{[1
]}

Mehta, Pramod ^{[1
]}

Yin, Min-Jean ^{[1
]}

Hickey, Michael J. ^{[1
]}

Gajiwala, Ketan S. ^{[1
]}

Rodgers, Caroline ^{[1
]}

Davies, Jay F., II ^{[1
]}

Gehring, Michael R. ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, La Jolla Labs, San Diego, CA 92121 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 01期

关键词：

POTENT ANTITUMOR-ACTIVITY; HEAT-SHOCK-PROTEIN-90; INHIBITORS; CANCER; PHARMACOKINETICS; METABOLISM; CLEARANCE; ASSAY;

D O I：

10.1021/jm901209q

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery and optimization of potency and metabolic stability of a novel class of dihyroxyphenylisoindoline amides as Hsp90 inhibitors are presented. Optimization of a screening hit using structure-based design and modification of log D and chemical structural features led to the identification of a class of orally bioavailable non-quinone-containing Hsp90 inhibitors. This class is exemplified by 14 and 15, which possess improved cell potency and pharmacokinetic profiles compared with the original screening hit.

引用

页码：499 / 503

页数：5

共 50 条

[21] Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
Sitko, Krzysztof
Bednarek, Marta
Mantej, Jagoda
Trzeciak, Magdalena
Tukaj, Stefan
CELL STRESS & CHAPERONES, 2021, 26 (06): : 1001 - 1007
[22] Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors (vol 434, pg 202, 2013)
Haginaka, Jun
Kitabatake, Tomoko
Hirose, Iyo
Matsunaga, Hisami
Moaddel, Ruin
ANALYTICAL BIOCHEMISTRY, 2013, 436 (02) : 65 - 65
[23] Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
Krzysztof Sitko
Marta Bednarek
Jagoda Mantej
Magdalena Trzeciak
Stefan Tukaj
Cell Stress and Chaperones, 2021, 26 : 1001 - 1007
[24] Heat Shock Protein 90 (Hsp90) in Fungal Growth and Pathogenesis
Lamoth F.
Juvvadi P.R.
Steinbach W.J.
Current Fungal Infection Reports, 2014, 8 (4) : 296 - 301
[25] Role of Heat Shock Protein 90 (Hsp90) in Insulin Secretion
Tamarina, Natalia A.
Philipson, Louis H.
DIABETES, 2013, 62 : A575 - A576
[26] Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
Basso, AD
Solit, DB
Chiosis, G
Giri, B
Tsichlis, P
Rosen, N
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39858 - 39866
[27] Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
Zagouri, Flora
Bournakis, Evangelos
Koutsoukos, Konstantinos
Papadimitriou, Christos A.
PHARMACEUTICALS, 2012, 5 (09): : 1008 - 1020
[28] Interaction of a Novel Chaperone PhLP2A With the Heat Shock Protein Hsp90
Krzemien-Ojak, Lucja
Goral, Agnieszka
Joachimiak, Ewa
Filipek, Anna
Fabczak, Hanna
JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (02) : 420 - 429
[29] The chaperone heat shock protein 90 (Hsp90) participates in the endothelial store operated calcium entry heterocomplex
Kadeba, Pierre I.
Scammell, Jonathan G.
Cioffi, Donna L.
FASEB JOURNAL, 2013, 27
[30] Heat shock protein 90-antagonist destabilizes Bcr-Abl/HSP90 chaperone complex
Shiotsu, Y
Soga, S
Akinaga, S
LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 961 - 968

← 1 2 3 4 5 →